Safety Alerts:

Thyroid Tumors: Alert your healthcare provider immediately if you notice neck lumps, hoarseness, swallowing difficulty, or shortness of breath.
Allergy Precautions: Do not use if allergic to semaglutide or other product components.
Usage Guidelines:

Age and Condition Restrictions: Not for type 1 diabetes or individuals under 18.
Medical History: Inform your doctor about any pancreatic, kidney, or vision issues related to diabetes, as well as pregnancy or breastfeeding status.
Administration:

Take precisely as directed by your doctor.
Consume on an empty stomach with water.
Avoid altering the tablet form (no splitting, crushing, or chewing).
Eat or take other oral medications 30 minutes after ingestion.
Common Side Effects:

May include nausea, abdominal pain, diarrhea, reduced appetite, vomiting, and constipation.
Weight Loss Benefits:

Not Just for Blood Sugar: Many patients experience significant weight loss while using RYBELSUS®.
Average Weight Loss: Patients typically lose around 2.3 kg with 7 mg and 3.7 kg with 14 mg dosages.
Feeling Fuller: RYBELSUS® can increase satiety after meals, aiding in weight reduction.
How it Works:

RYBELSUS® is a GLP-1 receptor agonist, which helps regulate blood sugar, especially post-meal, by stimulating insulin secretion and slowing gastric emptying.
Take the Next Step:

Consult with your healthcare provider to see if RYBELSUS® is right for you.
Read the RYBELSUS® medication guide for comprehensive information.
Remember: This summary is for educational purposes and does not replace professional medical advice. Always consult your healthcare provider for personalized guidance.